Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeMARKET REPORTSPeritoneal Dialysis Market is Estimated to Reach $5.58 Billion by 2027

Peritoneal Dialysis Market is Estimated to Reach $5.58 Billion by 2027

December 23, 2020

Peritoneal Dialysis Market is estimated to reach USD 5.58 Billion by 2027. This can be mainly associated with the growing incidences of chronic diseases and technological advancements that are expected to become the most common growth factors globally in the coming years.

Peritoneal dialysis (PD) is a method of dialysis that uses dialysis solution and the inner lining of the abdomen to drain blood when the kidneys are not functioning efficiently. This method is mostly performed at home and principally works to remove excess waste products and fluid from the blood. ESRD (End-stage renal disease), which is generally known as kidney failure, is a significant factor for the growth of the market.

Diabetes is the most common cause of ESRD, whereas high blood pressure is the second most common cause of ESRD. High blood pressure and diabetes are the most common chronic disease among the global population, and a shortage of kidneys for transplantation due to stringent regulations regarding kidney transplantation in several countries are some of the factors that are responsible for stimulating the market growth.

However, the lack of awareness and limited demand in underdeveloped countries are some factors that may hinder the market growth. The rise in demand for home peritoneal dialysis treatment and increased opportunities in weak and emerging markets would create future opportunities.

Due to the presence of key players, favorable reimbursement policies, and a rising number of chronic diseases, and several initiatives by the government, North America accounts for the largest share of around 35.3% of the market by 2019.

Further key findings from the report suggest

  • Peritoneal dialysis is the cleansing of blood and the elimination of extra fluids by using the peritoneal membrane, the body’s natural filter.
  • Hemodialysis is a method of pumping out the blood to an artificial kidney system and is returned to the body with the help of tubing accessories.
  • The peritoneal membrane is the lining that circles the abdominal cavity, including the stomach, spleen, liver, and intestines.
  • CAPD type segment is expected to grow at a rate of 5.4% during the forecast period due to portability, low cost, and freedom from machines.
  • The growing population, increasing rates of chronic diseases, and rising healthcare expenditure are the fundamental factors that are boosting the growth of the market across the globe.
  • A growing aging population that needs long term care requirements, raising awareness about hospital-acquired infections, and growing usage of technologies among patients are few factors that are expected to expand usage rates.
  • The hospital-based dialysis segment accounts for a market share of approximately 31.2% by 2019.
  • Innovative product development and collaborative developments are some critical strategic initiatives taken by the players in this industry to fortify their position in the competition.
  • The presence of unique diagnostic and therapeutic medical technologies that enable quick and accurate diagnosis is the primary factor for the growth of this segment.
  • The benefits of peritoneal dialysis involve no use of needles, minimum clinic visits, and continuous therapy supplies similar to the kidney’s natural functioning.
  • The peritoneal dialysis solution segment accounted for the largest share of nearly 23.3% by 2019.
  • Europe accounted for a share of about 26.3% in 2019 and is expected to grow at a rate of 5.3% during the forecast period.
  • Key participants include Nipro, Covidien, B. Braun Melsungen, Diversified Specialty Institute Holdings, DaVita Healthcare Partners, Baxter International, Dialysis Clinic, Medical Components, Northwest Kidney Centers, Fresenius Medical Care, Huaren Pharmaceutical, NephroPlus, Satellite Healthcare, NxStage Medical, Renal Services, Sandor, Sichuan Kelun Pharmaceutical, and U.S. Renal Care.

Key Topics Covered:

Chapter 1. Market Synopsis

Chapter 2. Executive Summary

Chapter 3. Indicative Metrics

Chapter 4. Peritoneal Dialysis Market Segmentation & Impact Analysis

Chapter 5. Peritoneal Dialysis Market By Type Insights & Trends

Chapter 6. Peritoneal Dialysis Market By End-User Insights & Trends

Chapter 7. Peritoneal Dialysis Market By Product Insights & Trends

Chapter 8. Peritoneal Dialysis Market Regional Outlook

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

  • Baxter International
  • Nipro
  • B. Braun Melsungen
  • DaVita Healthcare Partners Co.idien
  • Dialysis Clinic
  • Fresenius Medical Care
  • Diversified Specialty Institute Holdings
  • Medical Components
  • Huaren Pharmaceutical
  • NephroPlus
  • Northwest Kidney Centers
  • Satellite Healthcare
  • NxStage Medical
  • Renal Services
  • Sandor
  • Sichuan Kelun Pharmaceutical
  • U.S. Renal Care

For more information about this report visit here.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy